Protagonist Therapeutics Sees Stock Fluctuations Amid Biotech Innovations
Protagonist Therapeutics, a clinical-stage biopharmaceutical company, has seen notable stock performance, with a market capitalization of $3.34 billion and a price-to-earnings ratio of 71.08.
- Protagonist Therapeutics Inc
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
2 minutes to read